Electromed

Electromed, Inc. engages in the development, manufacture, marketing, and sale of medical equipment. The firm's products include SmartVest SQL System and SmartVest Connect. It focuses on building market awareness, and acceptance of its products and services with physicians, clinicians, patients, and third-party payers. The company was founded by Robert D. Hansen and Craig N. Hansen in 1992 and is headquartered in New Prague, MN.

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Earnings data Q1 2025

Earnings data Q2 2025

Electromed reports record Q1 revenues, faces CMS waiver expiration

Electromed delivered robust financial performance, driven by strong revenue growth and operational efficiency. The company faces challenges related to potential CMS waiver expiration and CEO succession, but strategic initiatives and market opportunities position it for continued growth. Overall, Electromed's focus on innovation and market expansion bodes well for future success.

Electromed reports record Q2 revenue, focuses on strategic growth

Electromed's Q2 2023 earnings call showcased strong financial performance, particularly in the home care segment. Despite challenges from the expiration of the CMS waiver, the company's strategic growth initiatives and clinical evidence present promising opportunities for future success.

Electromed Inc. reports robust Q3 earnings and targets market expansion

Electromed Inc. delivered strong financial performance in Q3 2023, driven by revenue growth and improved operational efficiency. The company's strategic initiatives and focus on quality assurance position it for continued success. However, managing expenses and balancing revenue across segments will be crucial for sustained growth.

Electromed (ELMD) reports record revenue and eyes growth opportunities

Electromed's Q4 2023 earnings call showcased impressive financial performance, with record revenue and operating income. The company's strategic focus on growth investments, operational excellence, and market development is driving strong results. While facing challenges in optimizing capital deployment, Electromed is well-positioned to leverage opportunities in expanding its market presence and driving further growth.

Electromed (ELMD) achieves record revenue in Q3 2024 earnings call

Electromed (ELMD) delivered robust financial performance in Q3 2024, driven by revenue growth and operational excellence. Despite challenges like a cyberattack and increased expenses, the company remains well-positioned with a strong cash position and growth strategies in place.

Electromed (ELMD) achieves record revenue and market expansion in Q4 2024

Electromed's Q4 2024 performance reflects strong revenue growth, operational excellence, and strategic market initiatives.
While facing challenges in maintaining growth momentum, the company's focus on innovation and market expansion positions it for future success.
With a solid financial position, diverse product portfolio, and growth strategies in place, Electromed is poised for continued growth and market leadership.

Electromed (ELMD) reports robust Q1 earnings and strategic growth plans

Electromed's Q1 2025 performance reflects strong revenue growth, improved profitability, and strategic investments in key areas.
The company's financial stability, operational efficiency, and focus on market expansion position them for sustained success in the medical device industry.
While challenges in maintaining growth persist, Electromed's proactive approach to innovation and market awareness presents opportunities for future expansion.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Hospital Market Release SmartVest Clearway, Fifth Generation HFCWO Airway Clearance Generator.

Electromed, Inc. Announces Hospital Market Release SmartVest Clearway, Fifth Generation HFCWO Airway Clearance Generator

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum.

Electromed, Inc. to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its First Quarter Fiscal 2024 Financial Results Conference Call for November 7, 2023 at 5:00 p.m. ET.

Electromed, Inc. Schedules its First Quarter Fiscal 2024 Financial Results Conference Call for November 7, 2023 at 5:00 p.m. ET

Electromed, Inc. (NYSE:ELMD ) Q4 2023 Earnings Call Transcript August 22, 2023 5:00 PM ET Company Participants Mike Cavanaugh - IR Jim Cunniff - President and CEO Brad Nagel - CFO Conference Call Participants Brooks O'Neil - Lake Street Operator Greetings, and welcome to Electromed's Fourth Quarter Fiscal Year 2023 Earnings Call. At this time, all participants are in a listen-only mode.

Electromed, Inc. (ELMD) Q4 2023 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results.

Electromed, Inc. Announces Fiscal 2023 Fourth Quarter and Full Year Financial Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Fourth Quarter Fiscal 2023 Financial Results Conference Call for August 22, 2023 at 5:00 p.m. ET.

Electromed, Inc. Schedules its Fourth Quarter Fiscal 2023 Financial Results Conference Call for August 22, 2023 at 5:00 p.m. ET

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Announces Grant of Inducement Equity Awards.

Electromed Announces Grant of Inducement Equity Awards

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Sidoti Summer Small Cap Conference.

Electromed, Inc. to Participate in the Sidoti Summer Small Cap Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed Names Jim Cunniff as President and Chief Executive Officer.

Electromed Names Jim Cunniff as President and Chief Executive Officer

Electromed continues to rally off previous lows and crossed above the 50DMA last week. SmartVest numbers are ratcheting higher, CMS waiver decision well priced into the equity level.

Electromed: May Reversal Vindicating Long-Term Buy Thesis

Electromed, Inc. (NYSE:ELMD ) Q3 2023 Results Conference Call May 9, 2023 5:00 PM ET Company Participants Mike Cavanaugh - Investor Relations Kathleen Skarvan - President and Chief Executive Officer Brad Nagel - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Operator Welcome to the Electromed Third Quarter Fiscal 2023 Financial Results Conference Call [Operator Instructions]. I will now turn the call over to your host, Mike Cavanaugh, Investor Relations.

Electromed, Inc. (ELMD) Q3 2023 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Announces Fiscal 2023 Third Quarter Results.

Electromed, Inc. Announces Fiscal 2023 Third Quarter Results

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. to Participate in the Inaugural EF Hutton Global Conference.

Electromed, Inc. to Participate in the Inaugural EF Hutton Global Conference

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET.

Electromed, Inc. Schedules its Third Quarter Fiscal 2023 Financial Results Conference Call for May 9, 2023 at 5:00 p.m. ET

Solid Q2 result with upsides versus consensus at the top and bottom lines. Sales force increase converting to further sales growth with >$950,000 in revenue/rep this quarter.

Electromed: Reiterating Buy With Sales Rep Conversions Driving Top-Line Growth

Electromed, Inc. (NYSE:ELMD ) Q2 2023 Earnings Conference Call February 14, 2023 5:00 PM ET Company Participants Mike Cavanaugh – Investor Relations Kathleen Skarvan – President and Chief Executive Officer Brad Nagel – Chief Financial Officer Conference Call Participants Brooks O'Neil – Lake Street Operator Greetings, and welcome to Electromed's Fiscal Second Quarter Earnings Call. At this time all participants are in a listen-only mode.

Electromed, Inc. (ELMD) Q2 2023 Earnings Call Transcript

NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc.

Electromed, Inc. Announces Fiscal 2023 Second Quarter Results

Electromed Announces Chief Executive Officer Retirement and Succession Plan

NEW PRAGUE, Minn.--( BUSINESS WIRE )--Electromed, Inc. (“Electromed” or the “Company”) (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced that it will issue its financial results press release for the fiscal 2023 second quarter ended December 31, 2022, on Tuesday, February 14, 2023 after the close of the stock market, and host a conference call the same day at 5:00 p.m. Eastern Time to discuss the results.

Electromed, Inc. Schedules its Second Quarter Fiscal 2023 Financial Results Conference Call for February 14, 2023 at 5:00 p.m. ET

Received 510(K) clearance for its SmartVest system last month. Meaningful alpha opportunity in helping patients with complex respiratory disorders, large addressable market.

Electromed: SmartVest Clearance Adds Alpha Opportunity, Rate Buy

NEW PRAGUE, Minn.--( BUSINESS WIRE )--Electromed, Inc. (NYSE American: ELMD) a leader in innovative airway clearance technologies, today announced that it received U.S Food and Drug Administration (“FDA”) 510(k) clearance of the SmartVest® Clearway® Airway Clearance System, which is designed for High Frequency Chest Wall Oscillation (“HFCWO”) therapy. The SmartVest Clearway system, an updated and modern approach to HFCWO, offers an enhanced patient experience with proven patient outcomes.1

Electromed, Inc. Announces U.S. Food and Drug Administration 510(k) Clearance of Fifth Generation HFCWO Airway Clearance Generator

Electromed, Inc. (NYSE:ELMD ) Q1 2023 Earnings Conference Call November 8, 2022 5:00 PM ET Company Participants Mike Cavanaugh - IR Kathleen Skarvan - CEO & President Michelle Wirtz - Interim CFO Conference Call Participants Operator Hello, and welcome to the Electromed Fiscal First Quarter 2023 Earnings Conference Call. All participants will be in listen-only mode.

News for Electromed Stock (ELMD)